Northern Trust Corp Catalent, Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Catalent, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,627,201 shares of CTLT stock, worth $98.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,627,201

Previous 1,645,867 1.13%

Holding current value

$98.2 Million

Previous $92.9 Million 1.52%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$53.58 - $57.02 $1 Million - $1.06 Million	-18,666 Reduced 1.13%	1,627,201 $91.5 Million
Q1 2024 May 14, 2024	SELL	$42.56 - $59.82 $17.5 Million - $24.6 Million	-410,899 Reduced 19.98%	1,645,867 $92.9 Million
Q4 2023 Feb 13, 2024	SELL	$32.18 - $46.57 $3.34 Million - $4.84 Million	-103,837 Reduced 4.81%	2,056,766 $92.4 Million
Q3 2023 Nov 13, 2023	BUY	$44.2 - $50.2 $11.4 Million - $13 Million	258,482 Added 13.59%	2,160,603 $98.4 Million
Q2 2023 Aug 11, 2023	SELL	$31.86 - $67.26 $6.03 Million - $12.7 Million	-189,201 Reduced 9.05%	1,902,121 $82.5 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $9.08 Million - $14.8 Million	199,884 Added 10.57%	2,091,322 $137 Million
Q4 2022 Feb 13, 2023	BUY	$41.39 - $81.0 $5.31 Million - $10.4 Million	128,253 Added 7.27%	1,891,438 $85.1 Million
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $4.05 Million - $6.34 Million	-56,028 Reduced 3.08%	1,763,185 $128 Million
Q2 2022 Aug 12, 2022	BUY	$87.2 - $114.05 $11.1 Million - $14.5 Million	127,056 Added 7.51%	1,819,213 $195 Million
Q1 2022 May 13, 2022	BUY	$94.19 - $124.49 $2.09 Million - $2.76 Million	22,177 Added 1.33%	1,692,157 $188 Million
Q4 2021 Feb 08, 2022	SELL	$119.57 - $139.07 $678,081 - $788,665	-5,671 Reduced 0.34%	1,669,980 $214 Million
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $41,266 - $53,808	-378 Reduced 0.02%	1,675,651 $223 Million
Q2 2021 Aug 13, 2021	BUY	$100.34 - $115.69 $1.12 Million - $1.29 Million	11,115 Added 0.67%	1,676,029 $181 Million
Q1 2021 May 12, 2021	BUY	$101.51 - $125.27 $1.22 Million - $1.51 Million	12,044 Added 0.73%	1,664,914 $175 Million
Q4 2020 Feb 11, 2021	SELL	$85.88 - $105.36 $879,840 - $1.08 Million	-10,245 Reduced 0.62%	1,652,870 $172 Million
Q3 2020 Nov 16, 2020	BUY	$72.74 - $92.5 $13.7 Million - $17.5 Million	188,943 Added 12.82%	1,663,115 $142 Million
Q2 2020 Aug 14, 2020	BUY	$48.02 - $79.04 $11.4 Million - $18.8 Million	237,361 Added 19.19%	1,474,172 $108 Million
Q1 2020 May 14, 2020	BUY	$36.95 - $62.95 $3.65 Million - $6.21 Million	98,661 Added 8.67%	1,236,811 $64.3 Million
Q4 2019 Feb 14, 2020	BUY	$47.06 - $56.64 $1.02 Million - $1.23 Million	21,630 Added 1.94%	1,138,150 $64.1 Million
Q3 2019 Nov 13, 2019	SELL	$47.45 - $58.05 $1.02 Million - $1.24 Million	-21,398 Reduced 1.88%	1,116,520 $53.2 Million
Q2 2019 Aug 13, 2019	SELL	$39.26 - $54.21 $367,198 - $507,026	-9,353 Reduced 0.82%	1,137,918 $61.7 Million
Q1 2019 May 13, 2019	BUY	$29.84 - $43.92 $1.24 Million - $1.83 Million	41,563 Added 3.76%	1,147,271 $46.6 Million
Q4 2018 Feb 12, 2019	BUY	$29.95 - $46.34 $215,969 - $334,157	7,211 Added 0.66%	1,105,708 $34.5 Million
Q3 2018 Nov 14, 2018	BUY	$40.12 - $45.55 $147,641 - $167,624	3,680 Added 0.34%	1,098,497 $50 Million
Q2 2018 Sep 18, 2018	SELL	$38.72 - $42.52 $336,941 - $370,009	-8,702 Reduced 0.79%	1,094,817 $45.9 Million
Q2 2018 Aug 14, 2018	SELL	$38.72 - $42.52 $35.8 Million - $39.3 Million	-925,153 Reduced 45.6%	1,103,519 $46.2 Million
Q1 2018 May 09, 2018	BUY	$39.4 - $47.39 $86,443 - $103,973	2,194 Added 0.11%	2,028,672 $83.3 Million
Q4 2017 Feb 14, 2018	BUY	$37.27 - $43.02 $168,758 - $194,794	4,528 Added 0.22%	2,026,478 $83.2 Million
Q3 2017 Nov 13, 2017	BUY	$33.75 - $41.67 $68.2 Million - $84.3 Million	2,021,950	2,021,950 $80.7 Million

Others Institutions Holding CTLT

# of Institutions

489

Shares Held

165M

Call Options Held

364K

Put Options Held

837K

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Catalent, Inc. Transaction History